Literature DB >> 6206156

Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.

M A Wabuke-Bunoti, A Taku, D P Fan, S Kent, R G Webster.   

Abstract

Two peptides corresponding to HA1(181-204) and HA2(103-123) of the A/Japan/305/57 influenza virus hemagglutinin (HA) were chemically synthesized by solid-phase methods and were tested for their ability to generate murine secondary anti-influenza cytolytic T lymphocytes (CTL) in vitro and to bind monoclonal anti-HA antibodies. Peptide HA1(181-204) could only generate CTL in the presence of helper factors contained in supernatant fluids from either Concanavalin A-stimulated mouse spleen cultures or WEHI-3 cells grown in vitro. Peptide HA2(103-123) stimulated the induction of anti-influenza CTL independent of helper factors, but the stimulation was also greatly increased if helper factors were added. A 10-fold molar excess of peptide HA2(103-123) was required to obtain optimal CTL activation over the quantities required in the HA1(181-204) system. This molar ratio remained unchanged, even in the presence of helper factors. Induction of influenza-specific CTL was antigen-dependent in both systems, even though some killing of noninfected target cells was also occasionally observed. Our results suggest that synthetic peptides can be recognized as antigenic determinants in the generation of H-2-restricted anti-viral CTL capable of killing appropriately infected target cells. The inability of peptide HA1(181-204) to generate sufficient help for CTL development suggests that certain regions of the HA can be recognized by CTL precursors, but not by all of the required helper cells. Peptide HA1(181-204) also reacted with three monoclonal anti-HA antibodies as well as mouse anti-influenza (A/Japan/305/57) immune sera. This antibody reactivity suggests the possibility of a shared antigenic epitope or region between T and B cells, and therefore provides new insight in our understanding of viral antigenicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Antigen-major histocompatibility complex-T cell receptors: inquiries into the immunological ménage à trois.

Authors:  J Klein
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.

Authors:  D A Thorley-Lawson; E S Israelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis.

Authors:  T Boon; A Van Pel
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin.

Authors:  T J Braciale; M T Sweetser; L A Morrison; D J Kittlesen; V L Braciale
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 5.  Recognition of influenza virus proteins by cytotoxic T lymphocytes.

Authors:  A R Townsend
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 6.  Distinguishable pathways of viral antigen presentation to T lymphocytes.

Authors:  L A Morrison; V L Braciale; T J Braciale
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 7.  Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.

Authors:  Brian P Dolan; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Mol Life Sci       Date:  2011-03-17       Impact factor: 9.261

8.  Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.

Authors:  Yeping Sun; Jun Liu; Meng Yang; Feng Gao; Jianfang Zhou; Yoshihiro Kitamura; Bin Gao; Po Tien; Yuelong Shu; Aikichi Iwamoto; Zhu Chen; George F Gao
Journal:  J Gen Virol       Date:  2009-12-02       Impact factor: 3.891

Review 9.  Human autologous tumor-specific T cells in malignant melanoma.

Authors:  C D Platsoucas
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

10.  Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.